Acurion Closes Oversubscribed $4.3 Million Seed Round to Advance AI-Driven Precision Oncology Platform

Funding led by TK Partners supports further clinical validation, regulatory preparation, and commercialization of OncoGaze™ SAN DIEGO, April 2, 2026 /PRNewswire/ -- Acurion, a precision oncology technology company advancing AI-driven cancer biomarker detection through its OncoGaze™...